Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/18/2025

Diagnosis and Treatment of Post-Camping Diarrhea

Diagnostic Approach

  • The American College of Physicians and Infectious Diseases Society recommends stool testing for parasites for travelers with diarrhea lasting ≥14 days, specifically testing for Giardia, Cryptosporidium, Cyclospora, and other intestinal parasites 1, 2
  • The Infectious Diseases Society of America suggests obtaining stool specimens for ova and parasite examination, with molecular testing (multiplex PCR panels) preferred when available for rapid and accurate diagnosis 1
  • A three-week duration classifies this as persistent diarrhea (>14 days), which has a higher frequency of protozoal pathogens and justifies parasitic evaluation, according to the Journal of Travel Medicine and Clinical Infectious Diseases 1, 3

Treatment Recommendations

  • The Centers for Disease Control and Prevention recommend that for persistent watery diarrhea lasting ≥14 days, empiric antimicrobial treatment should generally be avoided until diagnostic testing is completed, but consider empiric treatment with metronidazole or tinidazole for presumed giardiasis if the patient is significantly symptomatic and testing will be delayed 2, 4
  • The World Health Organization suggests metronidazole 250-500 mg three times daily for 5-7 days as standard therapy for giardiasis, while tinidazole 2 grams as a single dose is an alternative with better compliance 2, 4
  • The American Gastroenterological Association recommends fluid and electrolyte replacement as essential, as dehydration is a frequently identified risk factor for diarrhea-related complications, and oral rehydration solutions are preferred over plain water 2, 3

Critical Pitfalls to Avoid

  • The Infectious Diseases Society of America advises against using loperamide for persistent diarrhea >14 days or when parasitic infection is suspected, as it may prolong infection and cause complications including toxic megacolon 3, 1
  • The Centers for Disease Control and Prevention recommend reassessing for non-infectious conditions, including inflammatory bowel disease and post-infectious IBS, if symptoms persist despite appropriate antimicrobial therapy 4

Follow-Up Considerations

  • The American College of Gastroenterology suggests that if symptoms persist despite treatment or testing is negative, consider post-infectious functional bowel disease or IBS, which occurs in approximately 10-11% of patients after infectious diarrhea in travelers, and repeat stool testing with molecular methods if initial testing was culture-based only 1, 3